Somatropin

Category
peptide
Half-Life (t½)
SC: 2.6h · IV: 12m
Aliases
rhGH, Recombinant human growth hormone, Genotropin, Humatrope, Norditropin, Omnitrope, Saizen, Zomacton

Pharmacological Mechanism

Recombinant human 22 kDa growth hormone (191 aa, two intrachain disulfides, identical to pituitary somatotropin). Activates GHR (JAK2/STAT5) on hepatocytes → hepatic IGF-1 → systemic mitogenic / anabolic effects; direct effects at adipocytes (lipolysis) and myocytes. Plasma t½ ~2.6 h after SC injection; IGF-1 rise persists ~24 h, sustaining once-daily dosing. Long-acting derivatives (somapacitan, lonapegsomatropin) shift dosing to weekly.

Half-Life & Elimination Curve (SC: 2.6h · IV: 12m)

100%50%25%12.5%0%0h0×t½2.6h1×t½5.2h2×t½7.8h3×t½10.4h4×t½13h5×t½0×t½ (0h): 100% remaining (~1.7 µg/L)1×t½ (2.6h): 50% remaining (~0.848 µg/L)2×t½ (5.2h): 25% remaining (~0.424 µg/L)3×t½ (7.8h): 12.5% remaining (~0.212 µg/L)4×t½ (10.4h): 6.3% remaining (~0.106 µg/L)5×t½ (13h): 3.1% remaining (~0.053 µg/L)
Plasma (SC)t½ Decay (2.6h)
  • 0×t½0h100% (1.7 µg/L)
  • 1×t½2.6h50% (0.848 µg/L)
  • 2×t½5.2h25% (0.424 µg/L)
  • 3×t½7.8h12.5% (0.212 µg/L)
  • 4×t½10.4h6.3% (0.106 µg/L)
  • 5×t½13h3.1% (0.053 µg/L)
Elimination t½2.6h (SC)
Rate Constant (ke)0.267 h⁻¹
Time to Peak (Tmax)4.32h
Est. Peak (Cmax)1.7 µg/L
Clearance (CL)7.46 L/h
97% Washout (5×t½)13h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

References